The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Vaccines for tumour prevention
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 1×
“These findings fit in well with the burgeoning data on the role of T reg cells in controlling the reaction against self antigen”
ResultStewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Overview of the main outcomes in breast-cancer prevention trials
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 965
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. S., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., & Wang, R.-F. (2005) · Science · doi:10.1126/science.1113401 · Cited by 746
T-cell-antigen recognition and the immunological synapse
Huppa, J. B., & Davis, M. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1245 · Cited by 643
Cancer vaccines: between the idea and the reality
Finn, O. J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1150 · Cited by 636
Maloney, D. G., Grillo-López, A. J., Bodkin, D. J., White, C. A., Liles, T. M., Royston, I., Varns, C., Rosenberg, J., & Levy, R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3266 · Cited by 636
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1517 · Cited by 545
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
Willimsky, G., & Blankenstein, T. (2005) · Nature · doi:10.1038/nature03954 · Cited by 445
Disis, M. L., Gooley, T. A., Rinn, K., Davis, D., Piepkorn, M., Cheever, M. A., Knutson, K. L., & Schiffman, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.171 · Cited by 423
B cells inhibit induction of T cell-dependent tumor immunity
Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 419
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
Ercolini, A. M., Ladle, B. H., Manning, E. A., Pfannenstiel, L. W., Armstrong, T. D., Machiels, J.-P. H., Bieler, J. G., Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042167 · Cited by 399
Chemoprevention: an essential approach to controlling cancer
Sporn, M. B., & Suh, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc844 · Cited by 379
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
Rovero, S., Amici, A., Carlo, E. D., Bei, R., Nanni, P., Quaglino, E., Porcedda, P., Boggio, K., Smorlesi, A., Lollini, P.-L., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5133 · Cited by 356
Self-citationMoody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
What's wrong with our cancer models?
Kamb, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1635 · Cited by 335
Derangement of immune responses by myeloid suppressor cells
Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0443-2 · Cited by 335
Orthotopic models of cancer for preclinical drug evaluation
Bibby, M. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.021 · Cited by 315
MHC antigens and tumor escape from immune surveillance
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)83005-0 · Cited by 305
Melani, C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003) · Blood · doi:10.1182/blood-2003-01-0190 · Cited by 295
Self-citationAlgarra, I., Garc�a-Lora, A., Cabrera, T., Ruiz-Cabello, F., & Garrido, F. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0517-9 · Cited by 293
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Morgan, D. J., Kreuwel, H. T. C., Fleck, S., Levitsky, H. I., Pardoll, D. M., & Sherman, L. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.643 · Cited by 244
Nanni, P., Nicoletti, G., De Giovanni, C., Landuzzi, L., Di Carlo, E., Cavallo, F., Pupa, S. M., Rossi, I., Colombo, M. P., Ricci, C., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1195 · Cited by 230
Self-citationHER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Reilly, R. T., Gottlieb, M. B. C., Ercolini, A. M., Machiels, J. P., Kane, C. E., Okoye, F. I., Muller, W. J., Dixon, K. H., & Jaffee, E. M. (2000) · PubMed · Cited by 215
The role of models in understanding CD8+ T-cell memory
Antia, R., Ganusov, V. V., & Ahmed, R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1550 · Cited by 210
Hepatitis B Vaccination and Hepatocellular Carcinoma Rates in Boys and Girls
Chang, M.-H. (2000) · JAMA · doi:10.1001/jama.284.23.3040 · Cited by 196
Cavallo, F., Giovarelli, M., Forni, G., Signorelli, P., Musiani, P., Modesti, A., Brunda, M. J., & Colombo, M. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1049 · Cited by 171
Self-citationStroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.
Singh, S., Ross, S. R., Acena, M., Rowley, D. A., & Schreiber, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.139 · Cited by 170
Allione, A., Consalvo, M., Nanni, P., Lollini, P., Cavallo, F., Giovarelli, M., Forni, M., Gulino, A., Colombo, M. P., & Dellabona, P. (1994) · PubMed · Cited by 162
Self-citationAromatase Inhibitors for Breast Cancer Prevention
Cuzick, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.027 · Cited by 161
Nagata, Y., Furugen, R., Hiasa, A., Ikeda, H., Ohta, N., Furukawa, K., Nakamura, H., Furukawa, K., Kanematsu, T., & Shiku, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1336 · Cited by 156
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neuTransgenic Mice
Quaglino, E., Iezzi, M., Mastini, C., Amici, A. R. D., Pericle, F., Carlo, E. D., Pupa, S. M., Giovanni, C. D., Spadaro, M., Curcio, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2962 · Cited by 156
Self-citationBleeker, W. K., van Bueren, J. J. L., van Ojik, H. H., Gerritsen, A. F., Pluyter, M., Houtkamp, M., Halk, E., Goldstein, J., Schuurman, J., van Dijk, M. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4699 · Cited by 152
Reilly, R. T., Machiels, J.-P., Emens, L. A., Ercolini, A. M., Okoye, F. I., Lei, R. Y., Weintraub, D., & Jaffee, E. M. (2001) · PubMed · Cited by 151
Identification of tumour-associated t-cell epitopes for vaccine development
Stevanović, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc841 · Cited by 150
Massaia, M., Borrione, P., Battaglio, S., Mariani, S., Beggiato, E., Napoli, P., Voena, C., Bianchi, A., Coscia, M., Besostri, B., et al. (1999) · Blood · doi:10.1182/blood.v94.2.673 · Cited by 149
Jones, F. E., & Stern, D. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202698 · Cited by 148
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
Noguchi, Y., Jungbluth, A., Richards, E. C., & Old, L. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11798 · Cited by 143
Choudhury, A., Charo, J., Parapuram, S. K., Hunt, R. C., Hunt, D. M., Seliger, B., & Kiessling, R. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11497 · Cited by 139
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
Fabian, C. J., & Kimler, B. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.005 · Cited by 137
Animal models of tumor immunity, immunotherapy and cancer vaccines
Ostrand‐Rosenberg, S. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.003 · Cited by 136
Insulin‐Like Growth Factors and Neoplasia
Pollak, M. (2004) · Novartis Foundation symposium · doi:10.1002/0470869976.ch6 · Cited by 133
Fatal attraction: tumors beckon regulatory T cells
Shevach, E. M. (2004) · Nature Medicine · doi:10.1038/nm0904-900 · Cited by 131
Okamoto, T., Fujii, S., Huang, S. K. S., Hoon, D. S. �., Irie, R. F., Nizze, A. J., & Morton, D. L. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00411.x · Cited by 130
Curcio, C., Carlo, E. D., Clynes, R., Smyth, M. J., Boggio, K., Quaglino, E., Spadaro, M., Colombo, M. P., Amici, A. R. D., Lollini, P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317426 · Cited by 124
Self-citationGreiner, J. W., Zeytin, H. E., Anver, M. R., & Schlom, J. (2002) · PubMed · Cited by 118
Manjili, M. H., Wang, X., Chen, X., Martin, T. G., Repasky, E. A., Henderson, R. A., & Subjeck, J. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4054 · Cited by 115
Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.
Dakappagari, N. K., Douglas, D. B., Triozzi, P. L., Stevens, V. C., & Kaumaya, P. T. P. (2000) · PubMed · Cited by 110
Petersson, M., Charo, J., Salazar‐Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. J. F., & Kiessling, R. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2099 · Cited by 109
Sakai, Y., Morrison, B. J., Burke, J. D., Park, J.-M., Terabe, M., Janik, J. E., Forni, G., Berzofsky, J. A., & Morris, J. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3442 · Cited by 94
Self-citationPark, J. M., Terabe, M., Sakai, Y., Munasinghe, J., Forni, G., Morris, J. C., & Berzofsky, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4228 · Cited by 92
Self-citationImmunoprevention of Mammary Carcinoma in HER-2/ neu Transgenic Mice Is IFN-γ and B Cell Dependent
Nanni, P., Landuzzi, L., Nicoletti, G., Giovanni, C. D., Rossi, I., Croci, S., Astolfi, A., Iezzi, M., Carlo, E. D., Musiani, P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2288 · Cited by 91
Self-citationCappello, P., Triebel, F., Iezzi, M., Caorsi, C., Quaglino, E., Lollini, P., Amici, A. R. D., Carlo, E. D., Musiani, P., Giovarelli, M., et al. (2003) · PubMed · Cited by 89
Self-citationEpidemiology and Prevention of Breast Cancer
Colditz, G. A. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0157 · Cited by 88
Nanni, P., Pupa, S. M., Nicoletti, G., Giovanni, C. D., Landuzzi, L., Rossi, I., Astolfi, A., Ricci, C., Vecchi, R. D., Invernizzi, A. M., et al. (2000) · International Journal of Cancer · Cited by 86
Self-citationThe promise of genetically engineered mice for cancer prevention studies
Green, J. E., & Hudson, T. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1565 · Cited by 83
Degl'Innocenti, E., Grioni, M., Boni, A., Camporeale, A., Bertilaccio, M. T. S., Freschi, M., Monno, A., Arcelloni, C., Greenberg, N. M., & Bellone, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425531 · Cited by 78
Genetic immunization against neu /erbB2 transgenic breast cancer
Amici, A. R. D., Venanzi, F. M., & Concetti, A. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050519 · Cited by 75
Immunoprevention of cancer: is the time ripe?
Forni, G., Lollini, P., Musiani, P., & Colombo, M. P. (2000) · PubMed · Cited by 73
Self-citationLustgarten, J., Dominguez, A. L., & Cuadros, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200324427 · Cited by 71
Zeytin, H. E., Patel, A. C., Rogers, C. J., Canter, D. J., Hursting, S. D., Schlom, J., & Greiner, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3878 · Cited by 67
Immunity to Cancer Through Immune Recognition of Altered Self: Studies with Melanoma
Guevara-Patino, J. A., Turk, M. J., Wolchok, J. D., & Houghton, A. N. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90005-4 · Cited by 66
Cancer immunoprevention: tracking down persistent tumor antigens
Lollini, P., & Forni, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00030-3 · Cited by 66
Self-citationSpadaro, M., Ambrosino, E., Iezzi, M., Carlo, E. D., Sacchetti, P., Curcio, C., Amici, A. R. D., Wei, W., Musiani, P., Lollini, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1873 · Cited by 66
Self-citationPremalignant Lesions as Targets for Cancer Vaccines
Finn, O. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031787 · Cited by 53
Astolfi, A., Landuzzi, L., Nicoletti, G., Giovanni, C. D., Croci, S., Palladini, A., Ferrini, S., Iezzi, M., Musiani, P., Cavallo, F., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62339-5 · Cited by 45
Self-citationIinuma, T., Homma, S., Noda, T., Kufe, D. W., Ohno, T., & Toda, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17323 · Cited by 45
Immunobiology of Her-2/Neu Transgenic Mice
Pannellini, T., Forni, G., & Musiani, P. (2004) · Breast Disease · doi:10.3233/bd-2004-20105 · Cited by 44
Self-citationWang, X., Wang, J., Maughan, M. F., & Lachman, L. B. (2004) · Breast Cancer Research · doi:10.1186/bcr962 · Cited by 44
Rodolfo, M., Melani, C. C., Zilocchi, C., Cappetti, B., Luison, E., Arioli, I., Parenza, M., Canevari, S., & Colombo, M. P. (1998) · PubMed · Cited by 42
Cancer Prevention: A Global Perspective
Stewart, B. W., & Coates, A. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.132 · Cited by 36
Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
Vogt, A., Chuang, P., Hebert, J. L., Hwang, J., Lü, Y., Kopelovich, L., Athar, M., Bickers, D. R., & Epstein, E. H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031190 · Cited by 34
Immunological inhibition of carcinogenesis
Spadaro, M., Lanzardo, S., Curcio, C., Forni, G., & Cavallo, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0483-7 · Cited by 33
Self-citationStuck in the MUC on the long and winding road
Houghton, A. N., & Lloyd, K. O. (1998) · Nature Medicine · doi:10.1038/nm0398-270 · Cited by 33
Ritvo, P., Wilson, K. R., Willms, D., Upshur, R. E. G., for the CANVAC Sociobehavioural Study Group, Goldman, A., Kelvin, D., Rosenthal, K. L., Rinfret, A., Kaul, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1220 · Cited by 30
Correspondence 2: Cancer vaccines: pessimism in check
Timmerman, J. M., & Levy, R. (2004) · Nature Medicine · doi:10.1038/nm1204-1279a · Cited by 23
Fedele, M. J., Lang, C. H., & Farrell, P. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e877 · Cited by 19
Mechanisms of Tumor Escape from the Immune Response
Ochoa, A. (2002) · doi:10.1201/9780367804701 · Cited by 15
Steitz, J., Büchs, S., Tormo, D., Ferrer, A., Wenzel, J., Huber, C., Wölfel, T., Barbacid, M., Malumbres, M., & Tüting, T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21349 · Cited by 11
Cellular immunity for cancer chemoimmunotherapy?an overview
Mihich, E. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0423-6 · Cited by 8
Immunotherapy and immunoprevention of cancer: where do we stand?
Cavallo, F., Curcio, C., & Forni, G. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.717 · Cited by 7
Self-citation
Cited by
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
The anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Finn, O. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072739 · Cited by 774
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Metadata
- Authors
- Lollini, P.-L., Cavallo, F., Nanni, P., & Forni, G.
- Venue
- Nature Reviews Cancer
- Published
- 2006-03-01
- Volume
- 6
- Issue
- 3
- Pages
- 204-216
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1985558623
- Cited by
- 340
- References
- 95
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.